Project Grant R21EB038058
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $570,612 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) awarded April 7, 2026, with completion targeted for January 31, 2030. The grant funds development of advanced volumetric ultrasound systems that enable precise functional imaging, targeting, and...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of North Carolina at Chapel Hill $327,748 on August 13, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a generative artificial intelligence-based phantom airway simulator for three-dimensional endoscopy. The primary deliverables include a novel neural architecture capable of...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $696,824 Project Grant to the University of North Carolina at Chapel Hill on August 11, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, spanning through June 30, 2029, will develop a novel robust and interpretable multi-modal artificial intelligence/machine learning (AI/ML) framework designed...
- Federal Grant Award Summary Duke University, through its Office of Research Administration, received a $722,392 Project Grant award dated March 10, 2026, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, scheduled for completion by February 28, 2030, supports development of Four-Dimensional Smart Epidermal Photoacoustic Tomography...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $122,260 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) effective July 1, 2025 through June 30, 2027. The award supports development of radiofluorination methods and fluorine-18 (18F) labeled prosthetic groups designed to enable rapid, iterative...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering awarded The Johns Hopkins University a $477,360 Project Grant on August 14, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to enhance the robustness and accessibility of open-source, vendor-neutral magnetic resonance imaging (MRI) technology through the Pypulseq platform. The project, concluding July 31, 2027, delivers three...
- Federal Grant Award Summary Grant Overview The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Vanderbilt University a $542,947 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) effective March 3, 2026, through February 28, 2030, to develop fully non-invasive transcranial functional ultrasound imaging for adult humans. This research addresses a critical public health need by advancing a low-cost,...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $788,785 Project Grant award effective July 1, 2025, through April 30, 2029, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project will develop and disseminate the first knowledge-empowered deep learning pipeline for comprehensive processing and...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $414,079 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective June 1, 2026 through May 31, 2028, supports the development of factual medical large vision-language models (MED-LVLMs) designed to reduce hallucinations in radiology...
- Federal Grant Award Summary The University of Michigan received a $149,264 Project Grant award dated March 26, 2026, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project addresses a significant clinical gap by developing advanced Magnetic Resonance (MR) fingerprinting technology specifically optimized for cardiac imaging in patients with...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of North Carolina at Chapel Hill a Project Grant valued at $229,820 on June 15, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development and validation of a magnetic resonance imaging tool capable of real-time monitoring and quantification of gas release and diffusion from the vasculature into tissue following ultrasound-triggered microbubble disruption. Specifically, researchers will synthesize and characterize microbubbles filled with hyperpolarized xenon-129 gas, optimize their xenon retention and magnetic resonance relaxation properties, and employ real-time MR imaging and spectroscopy to monitor gas distribution across blood, interstitial, and tissue compartments. This research addresses a critical gap in imaging capabilities, as no existing tool can currently visualize gas diffusion from the bloodstream into distal organs. The imaging methodology developed through this award will enable better understanding of fundamental gas exchange physiology and optimization of emerging ultrasound-based therapeutic strategies, including blood-brain barrier opening, neuromodulation, and targeted delivery of drugs, genes, and gases for conditions such as cancer, stroke, and traumatic brain injury. The project is scheduled for completion by March 31, 2028.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $229.8k | 6/10/26 |